期刊文献+

脉血康胶囊治疗糖尿病合并冠心病的疗效观察 被引量:14

下载PDF
导出
摘要 目的探讨脉血康胶囊治疗糖尿病合并冠心病的临床效果。方法对100例糖尿病合并冠心病患者,随机分为治疗组和对照组,各50例。对照组常规给予降糖及硝酸异山梨酯、阿司匹林肠溶片、辛伐他汀治疗;治疗组在对照组基础上应用脉血康胶囊2粒,3次/日,连续观察2周心电图及临床症状改善情况。结果治疗组显效31例,有效15例,无效4例,总有效率92%;对照组显效14例,有效20例,无效16例,总有效率68%。两组总有效率比较有统计学意义(P<0.05),但血糖变化不明显。结论脉血康胶囊治疗糖尿病合并冠心病有较好的效果。
出处 《中西医结合心脑血管病杂志》 2014年第1期32-32,共1页 Chinese Journal of Integrative Medicine on Cardio-Cerebrovascular Disease
  • 引文网络
  • 相关文献

参考文献4

二级参考文献41

  • 1[1]Weitz JI,Buller HR.Direct thrombin inhibitors in acute coronary syndromes.Circulation,2002,105:1004-1011. 被引量:1
  • 2[2]Sarich TC,Wolzt M,Eriksson UG,et al.Effects of ximelagatran,an oral direct thrombin inhibitor,r-hirudin and enoxaparin on thrombin generation and platelet activation in healthy male subjects.J Am Coll Cardio,2003,41:557-564. 被引量:1
  • 3[3]The Direct Thrombin Inhibitor Trialists' Collaborative Group.Direct thrombin inhibitors in acute coronary syndromes:principal results of a meta-analysis based on individual patients' data.Lancet,2002,359:294-302. 被引量:1
  • 4[4]Organisation to Assess Strategies for Ischemic Syndromes (OASIS) Investigators.Comparison of the effects of two doses of recombinant hirudin compared with heparin in patients with acute myocardial ischemia without ST elevation:a pilot study.Circulation,1997,96:769-777. 被引量:1
  • 5[5]Organisation to Assess Strategies for Ischemic Syndromes (OASIS-2) Investigators.Effects of recombinant hirudin (lepirudin) compared with heparin on death,myocardial infarction,refractory angina,and revascularisation procedures in patients with acute myocardial ischaemia without ST elevation:a randomised trial.Lancet,1999,353:429-438. 被引量:1
  • 6[6]The Global Use of Strategies to Open Occluded Arteries (GUSTO) Ⅱb Investigators.A comparison of recombinant hirudin with heparin for the treatment of acute coronary syndromes.N Engl J Med,1996,335:775-782. 被引量:1
  • 7[7]White H.The hirulog and early reperfusion or occlusion (HERO)-2 trial investigators.Thrombin-specific anticoagulation with bivalirudin versus heparin in patients receiving fibrinolytic therapy for acute myocardial infarction:the HERO-2 randomised trial.Lancet,2001,348:1855-1863. 被引量:1
  • 8[8]Mehta SR,Eikelboom JW,Rupprecht H J,et al.Efficacy of hirudin in reducing cardiovascular events in patients with acute coronary syndrome undergoing early percutaneous coronary intervention.Eur Heart J,2002,23:117-123. 被引量:1
  • 9[9]Bittl JA,Strony J,Brinker JA,et al.Treatment with bivalirudin (Hirulog) as compared with heparin during coronary angioplasty for unstable or post infarction angina.Hirulog Angioplasty Study Investigators.N Engl J Med,1995,333:764-769. 被引量:1
  • 10[10]Bittl JA,Chaitman BR,Feit F,et al.Bivalirudin versus heparin during coronary angioplasty for unstable or postinfarction angina:Final report reanalysis of the bivalirudin angioplasty study.Am Heart J,2001,141:952-959. 被引量:1

共引文献36

同被引文献79

引证文献14

二级引证文献40

相关主题

;
使用帮助 返回顶部